Lawfare in the orphan drug space
43(B)log
NOVEMBER 19, 2021
This designation did not indicate that Valtoco was safe or effective for public use but, instead, operated to qualify Neurelis for various development incentives, like tax credits and potential exclusivity for seven years if the FDA ultimately approved Valtoco.”
56 
Let's personalize your content